RIA
CYTK icon

Regal Investment Advisors’s Cytokinetics CYTK Stock Holding History

Regal Investment Advisors’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-404
Closed -$2K – 1053
2015
Q2 		$2K Hold
404
– – ﹤0.01% 836
2015
Q1 		$3K Sell
404
-39
-9% -$291 ﹤0.01% 864
2014
Q4 		$4K Buy
+443
New +$1.9K ﹤0.01% 769

Other funds holding CYTK

LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Regal Investment Advisors's CYTK Position: Q3 2015 in Review

Regal Investment Advisors sold out of Cytokinetics (CYTK) in Q3 2015, closing a stake of 404 shares — an estimated $2K sold.

Regal Investment Advisors first reported a position in CYTK in Q4 2014 and held it in 3 quarters. The position peaked at $4K in Q4 2014. 105 funds tracked by Wall St. Rank hold CYTK as of Q3 2015.

  • Regal Investment Advisors reported no remaining Cytokinetics position as of Q3 2015 after selling out during the quarter.
  • Regal Investment Advisors sold 404 Cytokinetics shares in Q3 2015, an estimated $2K.
  • Regal Investment Advisors first reported a position in Cytokinetics in Q4 2014 and held it in 3 quarters.
  • Regal Investment Advisors's Cytokinetics position peaked at $4K in Q4 2014.
  • 105 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2015.

Based on Regal Investment Advisors's 13F filing for Q3 2015, filed 12 Nov 2015.